Upgrade to SI Premium - Free Trial

LFMDP (LFMDP)

23.36 +0.01 (0.04%)

Chart
Today 6M 1Y 5Y

Latest Headlines

Form SCHEDULE 13G LifeMD, Inc. Filed by: FEDERATED HERMES, INC. July 8, 2026 7:45 AM - SEC Filing LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock June 23, 2026 8:01 AM - Globe NewsWire Form 8-K LifeMD, Inc. For: Jun 22 June 22, 2026 8:26 AM - SEC Filing LifeMD to launch self-pay testosterone program with Antares Pharma June 22, 2026 8:01 AM - StreetInsider LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection June 22, 2026 8:00 AM - Globe NewsWire LifeMD names Umesh Sripad as chief technology officer June 1, 2026 8:05 AM - StreetInsider LifeMD Appoints Umesh Sripad as Chief Technology Officer June 1, 2026 8:05 AM - Globe NewsWire LifeMD to Participate in Upcoming Investor Conferences May 15, 2026 8:00 AM - Globe NewsWire Form 10-Q LifeMD, Inc. For: Mar 31 May 6, 2026 5:25 PM - SEC Filing Form 8-K LifeMD, Inc. For: May 06 May 6, 2026 5:06 PM - SEC Filing LifeMD Reports First Quarter 2026 Results May 6, 2026 4:06 PM - Globe NewsWire Form ARS LifeMD, Inc. For: Dec 31 April 30, 2026 4:26 PM - SEC Filing Form DEFA14A LifeMD, Inc. April 30, 2026 4:22 PM - SEC Filing Form DEFA14A LifeMD, Inc. April 30, 2026 4:18 PM - SEC Filing Form DEF 14A LifeMD, Inc. For: Apr 30 April 30, 2026 4:09 PM - SEC Filing LifeMD to Report First Quarter 2026 Financial Results on May 6 April 27, 2026 8:00 AM - Globe NewsWire Full Article List